首页|期刊导航|中国中西医结合杂志|基于GPR43/β-arrestin-2/IκBα/NF-κB通路探讨左归降糖通脉方对糖尿病大鼠血管内皮炎性保护的影响

基于GPR43/β-arrestin-2/IκBα/NF-κB通路探讨左归降糖通脉方对糖尿病大鼠血管内皮炎性保护的影响OA北大核心CSTPCD

Effect of Zuogui Jiangtang Tongmai Formula on Vascular Endothelial Inflammation Protection in Diabetic Rats Based on GPR43/β-arrestin-2/IκBα/NF-κB Pathway

中文摘要英文摘要

目的 研究左归降糖通脉方对2型糖尿病(T2DM)大鼠血管内皮功能障碍的影响与作用机制.方法 高脂饲料喂养联合链脲佐菌素腹腔注射的方法制备模型.将SD大鼠随机分为空白组、模型组、左归降糖通脉方低剂量(12g/kg,ZJTF-L)组、左归降糖通脉方高剂量(24g/kg,ZJTF-H)组、二甲双胍+阿托伐他汀(150mg/kg+10mg/kg、西药联用)组、短链脂肪酸(500 mg/kg,SCFAs)组,每组10只.干预结束后,采用透射电镜观察大鼠颈动脉超微结构变化;ELISA检测血清胰岛素(FINS)、糖化血红蛋白(HbA1c)、细胞间黏附分子1(ICAM-1)、血管内皮细胞黏附分子1(VCAM-1)、内皮素1(ET-1)、白细胞介素-1 β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)的水平;生化分析法检测血清一氧化氮(NO)的含量;分别采用Western Blot、qPCR检测G蛋白偶联受体43(GPR43)、β-抑制蛋白2(β-arrestin-2)、核因子κB抑制因子α(IκBα)、核因子κB p65(NF-κBp65)的蛋白表达与mRNA水平.结果 与空白组比较,模型组体重下降,血糖显著升高(P<0.01);HbA1c、FINS、IL-1 β、IL-6、TNF-α、ICAM-1、VCAM-1 及 ET-1水平明显升高,NO明显降低(P<0.01);内皮细胞肿胀,胞核皱缩,细胞形状不清晰;颈动脉GPR43、IκBα蛋白表达与mRNA水平显著降低(P<0.05,P<0.01),β-arrestin-2、NF-κBp65蛋白表达与mRNA水平显著升高(P<0.01).与模型组比较,药物干预各组体重升高、血糖下降(P<0.01);炎症因子、血管内皮功能各项指标均有所好转(P<0.05,P<0.01).ZJTF-H组颈动脉部分内皮脱落,胞核形状较规则;GPR43、IκBα蛋白表达与mRNA水平明显升高(P<0.05,P<0.01);β-arrestin-2、NF-κBp65蛋白表达与mRNA水平明显下降(P<0.01).结论 左归降糖通脉方可改善T2DM大鼠血管内皮功能障碍,其机制可能与调节GPR43/β-arrestin-2/IKBα/NF-κB信号通路有关.

Objective To study the effect and mechanism of Zuogui Jiangtang Tongmai Formula on vascular endothelial dysfunction in type 2 diabetes mellitus(T2DM)rats.Methods High fat feed combined with streptozotocin intraperitoneal injection was used to prepare the model.SD rats were randomly divided into blank group,model group,Zuogui Jiangtang Tongmai Formula low dose(12 g/kg,ZJTF-L)group,Zuogui Jiangtang Tongmai Formula high dose(24 g/kg,ZJTF-H)group,metformin+atorvastatin(150 mg/kg+10 mg/kg,Western medicine)group,short-chain fatty acid(500 mg/kg,SCFAs)group,10 in each group.After the intervention,the ultrastructural changes of carotid artery in rats were observed by transmission electron microscopy.Serum insulin(FINS)and glycosylated hemoglobin(HbAlc),intercellular adhesion molecule 1(ICAM-1),vascular endothelial cell adhesion molecule 1(VCAM-1),endothelin 1(ET-1),interleukin-1 β(IL-1 β),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)were detected by ELISA.The content of nitric oxide(NO)was detected by biochemical analysis.The protein expression and mRNA levels of G protein-coupled receptor 43(GPR43),β-suppressor protein 2(β-arrestin-2),nuclear factor κB suppressor α(IKBα)and nuclear factor KBp65(NF-κBp65)were detected by Western Blot and qPCR.Results Compared with blank group,body weight decreased and blood glucose increased significantly in model group(P<0.01).The levels of HbA1c,FINS,IL-1 β,IL-6,TNF-α,ICAM-1,VCAM-1 and ET-1 were significantly increased,while the levels of NO were significantly decreased(P<0.01).Endothelial cell swelling,nucleus shrinkage and cell shape was not clear.The protein expression and mRNA levels of GPR43 and IκBα in carotid artery significantly decreased(P<0.05,P<0.01),and the protein expression and mRNA levels of β-arrestin-2 and NF-KBp65 significantly increased(P<0.01).Compared with model group,body mass decreased and blood glucose increased in drug intervention groups(P<0.01).Inflammatory factors and vascular endothelial function indicators were improved(P<0.05,P<0.01).In ZJTF-H group,part of the carotid endothelium was exfoliated and the shape of the nucleus was more regular.The protein expression and mRNA levels of GPR43 and IκBα significantly increased(P<0.05,P<0.01).The protein expression and mRNA levels of β-arrestin-2 and NF-KBp65 significantly decreased(P<0.01).Conclusion Zuogui Jiangtang Tongmai Formula can improve vascular endothelial dysfunction in T2DM rats,and its mechanism may be related to the regulation of GPR43/β-arrestin-2/IκBα/NF-κB signaling pathway.

彭岚玉;李定祥;姚敬心;蔡昱哲;邓奕辉

湖南中医药大学中西医结合学院(长沙 410208)湖南中医药大学中医学院(长沙 410208)

左归降糖通脉方2型糖尿病G蛋白偶联受体43β-抑制蛋白2核因子κB抑制因子α核因子κB中药复方

Zuogui Jiangtang Tongmai Formulatype 2 diabetes mellitusG protein-coupled receptor 43β-inhibitory protein 2inhibitory factor of nuclear factor κB αnuclear factor κBChinese herbal compound

《中国中西医结合杂志》 2024 (005)

558-566 / 9

湖南省教育厅科学研究项目(No.20 A365,No.21A0228);湖南省中医药科研计划项目(No.E2022010);湖南中医药大学中西医结合一流学科开放基金(No.2020ZXYJH31)

10.7661/j.cjim.20231016.303

评论